Header Logo

Connection

Mayer Davidson to Insulin, Short-Acting

Back to Details
This is a "connection" page, showing publications Mayer Davidson has written about Insulin, Short-Acting.
Mayer Davidson
Connection Strength
0.158
Insulin, Short-Acting
  1. Review: Rapid-acting analogues do not differ from regular human insulin for mortality or HbA1c in type 2 diabetes. Ann Intern Med. 2019 04 16; 170(8):JC39.
    View in: PubMed
    Score: 0.158
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.